|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-.--% | -1.26% |
| 08-07 | Stockholm's stock market falls in early Friday trading | FW |
| 08-07 | ASTRAZENECA PLC : Jefferies reaffirms its Buy rating | ZD |
Company Valuation: AstraZeneca PLC
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 182,034 | 209,442 | 209,268 | 203,171 | 287,813 | 248,994 | - | - |
| Change | - | 15.06% | -0.08% | -2.91% | 41.66% | -13.49% | - | - |
| Enterprise Value (EV) 1 | 206,417 | 232,365 | 231,778 | 227,741 | 311,187 | 268,775 | 261,303 | 253,073 |
| Change | - | 12.57% | -0.25% | -1.74% | 36.64% | -13.63% | -2.78% | -3.15% |
| P/E | 1,469x | 64.1x | 35.4x | 29.1x | 28.4x | 20.6x | 17.9x | 15.6x |
| PBR | 4.24x | 5.65x | 5.39x | 5.02x | 5.96x | 4.62x | 4.1x | 3.48x |
| PEG | - | 0x | 0.4x | 1.6x | 0.6x | 1.1x | 1.2x | 1x |
| Capitalization / Revenue | 4.87x | 4.72x | 4.57x | 3.76x | 4.9x | 3.94x | 3.72x | 3.49x |
| EV / Revenue | 5.52x | 5.24x | 5.06x | 4.21x | 5.3x | 4.25x | 3.91x | 3.55x |
| EV / EBITDA | 27.2x | 25.2x | 17.1x | 13.6x | 16x | 12.1x | 10.7x | 9.46x |
| EV / EBIT | 20.8x | 17.4x | 15.9x | 13.5x | 16.8x | 12.7x | 11.2x | 9.9x |
| EV / FCF | 42.4x | 26.7x | 25.8x | 22.9x | 26.5x | 28x | 20.2x | 17.6x |
| FCF Yield | 2.36% | 3.75% | 3.88% | 4.36% | 3.78% | 3.57% | 4.94% | 5.68% |
| Dividend per Share 2 | 2.87 | 2.9 | 2.9 | 3.1 | 3.2 | 3.325 | 3.527 | 3.662 |
| Rate of return | 2.44% | 2.15% | 2.15% | 2.37% | 1.72% | 2.07% | 2.2% | 2.28% |
| EPS 2 | 0.08 | 2.11 | 3.81 | 4.5 | 6.54 | 7.8 | 8.957 | 10.31 |
| Distribution rate | 3,588% | 137% | 76.1% | 68.9% | 48.9% | 42.6% | 39.4% | 35.5% |
| Net sales 1 | 37,417 | 44,351 | 45,811 | 54,073 | 58,739 | 63,245 | 66,851 | 71,298 |
| EBITDA 1 | 7,586 | 9,237 | 13,580 | 16,691 | 19,476 | 22,269 | 24,395 | 26,750 |
| EBIT 1 | 9,928 | 13,350 | 14,534 | 16,928 | 18,478 | 21,088 | 23,265 | 25,566 |
| Net income 1 | 112 | 3,288 | 5,961 | 7,035 | 10,225 | 12,070 | 13,716 | 15,668 |
| Net Debt 1 | 24,383 | 22,923 | 22,510 | 24,570 | 23,374 | 19,780 | 12,308 | 4,079 |
| Reference price 2 | 117.51 | 135.16 | 135.02 | 131.05 | 185.60 | 160.54 | 160.54 | 160.54 |
| Nbr of stocks (in thousands) | 1,549,159 | 1,549,528 | 1,549,926 | 1,550,317 | 1,550,726 | 1,551,024 | - | - |
| Announcement Date | 2/10/22 | 2/9/23 | 2/8/24 | 2/6/25 | 2/10/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 33.6x | 12.3x | 24.81x | 0.58% | 1,057B | ||
| 28.84x | - | - | 2.07% | 625B | ||
| 32.43x | 7.35x | 15.3x | 2.81% | 435B | ||
| 20.47x | 4.85x | 12.02x | 2.72% | 363B | ||
| 22.14x | 5.72x | 14.28x | 2.8% | 296B | ||
| 20.58x | 4.25x | 12.07x | 2.07% | 249B | ||
| 25.76x | 6.78x | 12.06x | 2.45% | 222B | ||
| 13.84x | 4.97x | 10.44x | 3.68% | 209B | ||
| -41.37x | 5.93x | 33.46x | 2.47% | 165B | ||
| Average | 17.37x | 6.52x | 16.80x | 2.41% | 402.31B | |
| Weighted average by Cap. | 24.45x | 8.09x | 18.31x | 1.98% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- AZN Stock
- ZEGA Stock
- Valuation AstraZeneca PLC
Select your edition
All financial news and data tailored to specific country editions
















